VBIV RSI Chart
Last 7 days
1.6%
Last 30 days
3.3%
Last 90 days
-3.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 9.4M | 0 | 0 | 0 |
2023 | 1.4M | 1.8M | 8.1M | 8.7M |
2022 | 456.0K | 660.0K | 870.0K | 1.1M |
2021 | 947.0K | 905.0K | 714.0K | 631.0K |
2020 | 2.3M | 1.8M | 1.5M | 1.1M |
2019 | 3.1M | 2.8M | 2.5M | 2.2M |
2018 | 916.0K | 806.0K | 872.0K | 2.1M |
2017 | 627.0K | 889.0K | 801.0K | 865.0K |
2016 | 853.3K | 751.5K | 649.8K | 548.0K |
2015 | 0 | 0 | 0 | 955.0K |
Which funds bought or sold VBIV recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | Community Bank, N.A. | unchanged | - | 5.00 | 169 | -% |
May 15, 2024 | CAPTRUST FINANCIAL ADVISORS | reduced | -0.06 | 182 | 7,434 | -% |
May 15, 2024 | Alyeska Investment Group, L.P. | unchanged | - | 9,459 | 377,490 | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | sold off | -100 | -14,437 | - | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | reduced | -24.48 | -2,919 | 10,028 | -% |
May 15, 2024 | PERCEPTIVE ADVISORS LLC | reduced | -8.66 | -57,973 | 757,026 | 0.01% |
May 15, 2024 | Royal Bank of Canada | reduced | -11.2 | - | - | -% |
May 15, 2024 | GOLDMAN SACHS GROUP INC | added | 2.72 | 955 | 18,794 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | reduced | -90.44 | -38,389 | 4,175 | -% |
May 15, 2024 | Alpine Global Management, LLC | unchanged | - | 377 | 15,065 | -% |
Unveiling VBI Vaccines Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to VBI Vaccines Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
VBI Vaccines Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 42.3% | 1,214,000 | 853,000 | 6,624,000 | 720,000 | 485,000 | 293,000 | 317,000 | 346,000 | 126,000 | 81,000 | 107,000 | 142,000 | 301,000 | 164,000 | 298,000 | 184,000 | 415,000 | 574,000 | 647,000 | 640,000 | 360,000 |
Cost Of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2,420,500 | 2,111,000 | 2,060,000 | 2,577,000 | 2,489,500 | 1,977,000 | 2,354,000 | 1,179,000 |
Operating Expenses | -8.8% | 12,966,000 | 14,215,500 | 16,693,000 | 37,692,000 | 19,994,000 | 21,732,000 | 21,875,000 | 23,249,000 | 16,046,000 | 20,952,000 | 15,131,000 | 16,583,000 | 15,998,000 | 14,374,500 | 12,151,000 | 8,326,000 | 9,828,000 | 10,742,000 | 16,790,000 | 12,909,000 | 14,179,000 |
S&GA Expenses | -13.9% | 7,671,000 | 8,906,000 | 9,036,000 | 10,917,000 | 13,284,000 | 15,886,000 | 14,220,000 | 15,084,000 | 10,930,000 | 12,528,000 | 9,693,000 | 9,367,000 | 6,747,000 | 7,130,500 | 5,562,000 | 3,901,000 | 4,058,000 | -2,476,000 | 9,412,000 | 3,194,000 | 3,960,000 |
R&D Expenses | 87.9% | 2,571,000 | 1,368,000 | 1,532,000 | 3,292,000 | 3,151,000 | 2,518,000 | 4,983,000 | 5,643,000 | 2,362,000 | 5,165,500 | 2,972,000 | 4,582,000 | 6,839,000 | 4,823,500 | 4,478,000 | 2,365,000 | 3,193,000 | 4,436,500 | 5,401,000 | 7,361,000 | 9,040,000 |
EBITDA Margin | 18.6% | -7.91 | -9.73 | -13.06 | -61.36 | -78.56 | -99.11 | -120 | -145 | -148 | -100 | -85.13 | -64.36 | - | - | - | - | - | - | - | - | - |
Interest Expenses | -9.1% | 1,565,000 | 1,721,000 | 1,543,000 | 1,708,000 | 1,429,000 | 1,208,000 | 958,000 | 901,000 | 940,000 | 1,049,000 | 1,026,000 | 845,000 | 1,812,000 | 65,000 | 742,000 | 682,000 | 475,000 | 524,000 | 626,000 | 566,000 | 480,000 |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | -137592.3% | -17,900,000 | -13,000 | -20,444,000 | -44,628,000 | -27,751,000 | -21,141,000 | -25,209,000 | -45,699,000 | -21,254,000 | -18,783,000 | -15,847,000 | -17,476,000 | -17,647,000 | -15,362,000 | -12,997,000 | -9,513,000 | -8,358,000 | -10,875,000 | -16,162,000 | -13,170,000 | -14,606,000 |
EBT Margin | 17.5% | -8.82 | -10.69 | -14.03 | -65.42 | -83.14 | -104 | -127 | -153 | -160 | -110 | -92.90 | -70.15 | - | - | - | - | - | - | - | - | - |
Net Income | -137592.3% | -17,900,000 | -13,000 | -20,444,000 | -44,628,000 | -27,751,000 | -21,141,000 | -25,209,000 | -45,699,000 | -21,254,000 | -18,783,000 | -15,847,000 | -17,476,000 | -17,647,000 | -15,362,000 | -12,997,000 | -9,513,000 | -8,358,000 | -10,875,000 | -16,162,000 | -13,170,000 | -14,606,000 |
Net Income Margin | 17.5% | -8.82 | -10.69 | -14.03 | -65.42 | -83.14 | -104 | -127 | -153 | -160 | -110 | -92.90 | -70.15 | - | - | - | - | - | - | - | - | - |
Free Cashflow | 2.5% | -11,921,000 | -12,227,000 | -8,073,000 | -19,260,000 | -22,190,000 | -20,498,000 | -18,574,000 | -18,527,000 | -20,440,000 | -19,126,000 | -4,455,000 | -11,122,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -13.2% | 75.00 | 87.00 | 101 | 88.00 | 128 | 155 | 172 | 172 | 194 | 210 | 224 | 225 | 223 | 209 | 200 | 161 | 107 | 122 | 132 | 115 | 126 |
Current Assets | -27.2% | 26.00 | 36.00 | 50.00 | 32.00 | 52.00 | 78.00 | 96.00 | 93.00 | 112 | 130 | 148 | 146 | 146 | 132 | 126 | 89.00 | 38.00 | 47.00 | 57.00 | 33.00 | 46.00 |
Cash Equivalents | -100.0% | - | 24.00 | 35.00 | 21.00 | 40.00 | 63.00 | 84.00 | 82.00 | 101 | 122 | 137 | 135 | 108 | 94.00 | 95.00 | 61.00 | 36.00 | 44.00 | 53.00 | 30.00 | 43.00 |
Inventory | 17.0% | 10.00 | 8.00 | 8.00 | 7.00 | 7.00 | 7.00 | 6.00 | 4.00 | 4.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Net PPE | -6.0% | 9.00 | 10.00 | 9.00 | 10.00 | 12.00 | 12.00 | 11.00 | 11.00 | 11.00 | 11.00 | 10.00 | 10.00 | 10.00 | 11.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Goodwill | -2.0% | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 9.00 | 8.00 |
Current Liabilities | 2.5% | 78.00 | 76.00 | 77.00 | 28.00 | 30.00 | 37.00 | 35.00 | 41.00 | 34.00 | 33.00 | 33.00 | 26.00 | 24.00 | 17.00 | 14.00 | 15.00 | 29.00 | 30.00 | 30.00 | 35.00 | 23.00 |
Long Term Debt | - | - | - | - | 48.00 | 49.00 | 49.00 | 48.00 | 21.00 | 25.00 | 28.00 | 28.00 | 27.00 | 16.00 | 16.00 | 16.00 | 15.00 | - | - | - | - | - |
LT Debt, Current | -4.0% | 49.00 | 51.00 | 50.00 | 2.00 | - | - | - | 9.00 | 5.00 | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | - | - | - | - | 48.00 | 49.00 | 49.00 | 48.00 | 21.00 | 25.00 | 28.00 | 28.00 | 27.00 | 16.00 | 16.00 | 16.00 | 15.00 | - | - | - | - | - |
Shareholder's Equity | -172.6% | -5.47 | 8.00 | 20.00 | 9.00 | 45.00 | 64.00 | 84.00 | 106 | 130 | 144 | 160 | 168 | 180 | 172 | 166 | 127 | 74.00 | 88.00 | 97.00 | 76.00 | 87.00 |
Retained Earnings | -3.1% | -600 | -582 | -582 | -561 | -517 | -489 | -468 | -443 | -397 | -378 | -359 | -343 | -326 | -308 | -293 | -280 | -270 | -262 | -251 | -235 | -222 |
Additional Paid-In Capital | 0.5% | 108 | 107 | 106 | 94.00 | 92.00 | 90.00 | 88.00 | 84.00 | 81.00 | 82.00 | 79.00 | 77.00 | 78.00 | 76.00 | 74.00 | 73.00 | 67.00 | 66.00 | 66.00 | 65.00 | 64.00 |
Shares Outstanding | 5.5% | 25.00 | 24.00 | 23.00 | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | 8.00 | 8.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 22.00 | - | - | - | 155 | - | - | - | 621 | - | - | - | 499 | - | - | - | 79.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 2.4% | -11,770 | -12,057 | -7,960 | -19,210 | -21,656 | -19,046 | -17,274 | -17,450 | -19,925 | -18,516 | -4,030 | -10,718 | -6,644 | -16,495 | -15,100 | -7,807 | -7,648 | -8,530 | -13,878 | -12,284 | -14,020 |
Share Based Compensation | -60.8% | 579 | 1,476 | 1,500 | 1,674 | 2,011 | 2,327 | 2,412 | 2,457 | 2,502 | 2,537 | 2,529 | 2,423 | 2,139 | 1,533 | 1,493 | 1,074 | 1,187 | 815 | 876 | 982 | 1,262 |
Cashflow From Investing | 11.2% | -151 | -170 | -113 | -50.00 | -534 | -1,452 | -1,300 | -1,077 | -515 | -610 | -425 | 24,747 | -556 | -532 | -200 | -25,135 | -133 | -186 | -586 | -1,005 | -1,896 |
Cashflow From Financing | 209.9% | 843 | 272 | - | - | - | - | 19,437 | - | 12.00 | 2,892 | 7,055 | 12,722 | 21,624 | 15,525 | 49,294 | 58,173 | -600 | -79.00 | - | - | - |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenues, net | $ 1,214 | $ 485 |
Operating expenses: | ||
Cost of revenues | 2,724 | 3,559 |
Research and development | 2,571 | 3,151 |
Sales, general and administrative | 7,671 | 13,284 |
Total operating expenses | 12,966 | 19,994 |
Loss from operations | (11,752) | (19,509) |
Interest expense, net of interest income | (1,818) | (1,429) |
Foreign exchange loss | (4,330) | (6,813) |
Loss before income taxes | (17,900) | (27,751) |
Income tax expense | ||
NET LOSS | (17,900) | (27,751) |
Other comprehensive income | 3,484 | 6,599 |
COMPREHENSIVE LOSS | $ (14,416) | $ (21,152) |
Net loss per share of common shares, basic | $ (0.73) | $ (3.22) |
Net loss per share of common shares, diluted | $ (0.73) | $ (3.22) |
Weighted-average number of common shares outstanding, basic | 24,584,798 | 8,608,539 |
Weighted-average number of common shares outstanding, diluted | 24,584,798 | 8,608,539 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
CURRENT ASSETS | ||
Cash | $ 12,595 | $ 23,685 |
Accounts receivable, net | 227 | |
Inventory, net | 9,944 | 8,499 |
Prepaid expenses | 1,601 | 2,284 |
Other current assets | 1,994 | 1,763 |
Total current assets | 26,361 | 36,231 |
NON-CURRENT ASSETS | ||
Other long-term assets | 1,206 | 1,178 |
Property and equipment, net | 9,088 | 9,665 |
Right of use assets | 1,947 | 2,248 |
Intangible assets, net | 35,734 | 36,499 |
Goodwill | 1,107 | 1,130 |
Total non-current assets | 49,082 | 50,720 |
TOTAL ASSETS | 75,443 | 86,951 |
CURRENT LIABILITIES | ||
Accounts payable | 8,871 | 6,431 |
Other current liabilities | 9,528 | 10,284 |
Current portion of deferred revenues | 9,619 | 7,276 |
Current portion of lease liability | 831 | 976 |
Current portion of long-term debt, net of debt discount | 48,745 | 50,769 |
Total current liabilities | 77,594 | 75,736 |
NON-CURRENT LIABILITIES | ||
Deferred revenues, net of current portion | 1,608 | 1,832 |
Lease liability, net of current portion | 1,136 | 1,295 |
Liabilities for severance pay | 572 | 561 |
Total non-current liabilities | 3,316 | 3,688 |
COMMITMENTS AND CONTINGENCIES (NOTE 16) | ||
STOCKHOLDERS’ EQUITY (DEFICIT) | ||
Common shares (unlimited authorized; no par value) (March 31, 2024 issued and outstanding – 25,236,766; December 31, 2023 issued and outstanding – 23,918,983) | 455,057 | 454,214 |
Additional paid-in capital | 108,010 | 107,431 |
Accumulated other comprehensive income | 31,811 | 28,327 |
Accumulated deficit | (600,345) | (582,445) |
Total stockholders’ equity (deficit) | (5,467) | 7,527 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | $ 75,443 | $ 86,951 |